Navigation Links
ZyDoc® e-Transcription Solutions

ProductsZyDoc® e-Transcription Solutions
Company AMTSystems
Item ZyDoc® e-Transcription Solutions
Features 
  • 24 hour turnaround time (standard, faster times available)
  • ZipIT™ v-10, the proprietary HIPAA-secure file transfer application is more robust and user friendly
  • VPN or full integration
  • Tracking capabilities (TrackDoc™), which posts the audio online to track the status of the job, posts completed documents, making patient information available to doctors, regardless of their location
  • Online editing and e-signature capabilities
  • Centralized location for all your completed documents
  • Automated distribution (premium full service document distribution to your referring network)
Description ZyDoc offers a full medical transcription and documentation solution.
Info  AMTSystems
Customer Service: 800-569-9059
Web site: http://www.amtsystems.com/rfid/index.cfm

Related medicine products :

1. Lobob Hard Lens Cleaning Solutions
2. Hard Lens Solutions
3. Lobob Hard Lens Soaking Solutions
4. MaximEyes Practice Management and Electronic Medical Records Software Solutions
5. Wright-Giemsa Stain Solutions
6. Wright Stain Solutions
7. TrackDoc Automated Medical Information Solutions
8. Suction Catheter Mini Soft Kits without Solutions
9. Sterile Tracheostomy Clean & Care Tray with Solutions
10. Trach Clean & Care Tray with Solutions
11. InfoLogix RFID Solutions
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 1ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 2ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 3Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 1Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 1Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 3Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 4